Statins accelerate disease progression and shorten survival in SOD1(G93A) mice.
Xiaowei W SuWint NandarElizabeth B NeelyZachary SimmonsJames R ConnorPublished in: Muscle & nerve (2016)
Statins and Hfe genotype alter disease course in the ALS mouse model. Because the H63D HFE polymorphism is present in 30% of patients with ALS, studying disease progression in patients who receive statins, stratified for HFE genotype, may guide therapy. Muscle Nerve, 2016 Muscle Nerve 54: 284-291, 2016.